Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes

BACKGROUND: We previously reported the effect of sitagliptin or glimepiride treatment for 24 weeks on body composition in Japanese overweight and obese patients with type 2 diabetes. Although the degree of HbA1c reduction was similar between the two groups, significant reduction of intrahepatic lipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishii, Satoshi, Nagai, Yoshio, Kato, Hiroyuki, Fukuda, Hisashi, Tanaka, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011940/
https://www.ncbi.nlm.nih.gov/pubmed/32095182
http://dx.doi.org/10.14740/jocmr4078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011940/
https://www.ncbi.nlm.nih.gov/pubmed/32095182
http://dx.doi.org/10.14740/jocmr4078

Ejemplares similares